190 related articles for article (PubMed ID: 11305762)
1. Low-field interventional MRI in neurosurgery: finding the right dose of contrast medium.
Knauth M; Wirtz CR; Aras N; Sartor K
Neuroradiology; 2001 Mar; 43(3):254-8. PubMed ID: 11305762
[TBL] [Abstract][Full Text] [Related]
2. MR enhancement of brain lesions: increased contrast dose compared with magnetization transfer.
Knauth M; Forsting M; Hartmann M; Heiland S; Balzer T; Sartor K
AJNR Am J Neuroradiol; 1996; 17(10):1853-9. PubMed ID: 8933869
[TBL] [Abstract][Full Text] [Related]
3. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
[TBL] [Abstract][Full Text] [Related]
4. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
7. Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.
van Waesberghe JH; Castelijns JA; Roser W; Silver N; Yousry T; Lycklama à Nijeholt GJ; Adèr HJ; Uitdehaag BM; Radue EW; Polman CH; Kappos L; Miller DH; Barkhof F
AJNR Am J Neuroradiol; 1997 Aug; 18(7):1279-85. PubMed ID: 9282855
[TBL] [Abstract][Full Text] [Related]
8. Half-dose gadolinium-enhanced MR imaging with magnetization transfer technique in brain tumors: comparison with conventional contrast-enhanced MR imaging.
Han D; Chang KH; Han MH; Cho JY; Han SW; Kim HD; Seong SO
AJR Am J Roentgenol; 1998 Jan; 170(1):189-93. PubMed ID: 9423630
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cerebral diseases: how much contrast agent is enough? Comparison of 0.1, 0.2, and 0.3 mmol/kg gadoteridol at 0.2 T with 0.1 mmol/kg gadoteridol at 1.5 T.
Brekenfeld C; Foert E; Hundt W; Kenn W; Lodeann KP; Gehl HB
Invest Radiol; 2001 May; 36(5):266-75. PubMed ID: 11323514
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of optimized gadolinium-enhanced fast fluid-attenuated inversion recovery MR imaging in revealing lesions of the brain.
Melhem ER; Bert RJ; Walker RE
AJR Am J Roentgenol; 1998 Sep; 171(3):803-7. PubMed ID: 9725320
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of brain metastases: magnetisation transfer or triple dose gadolinium?
Thng CH; Tay KH; Chan LL; Lim EH; Khoo BK; Huin EL; Tan KP
Ann Acad Med Singap; 1999 Jul; 28(4):529-33. PubMed ID: 10561767
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.
Limanond P; Raman SS; Sayre J; Lu DS
J Magn Reson Imaging; 2004 Oct; 20(4):640-7. PubMed ID: 15390231
[TBL] [Abstract][Full Text] [Related]
13. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases.
Ba-Ssalamah A; Nöbauer-Huhmann IM; Pinker K; Schibany N; Prokesch R; Mehrain S; Mlynárik V; Fog A; Heimberger K; Trattnig S
Invest Radiol; 2003 Jul; 38(7):415-22. PubMed ID: 12821855
[TBL] [Abstract][Full Text] [Related]
14. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
[TBL] [Abstract][Full Text] [Related]
15. Gd-enhanced MR imaging of brain metastases: contrast as a function of dose and lesion size.
Van Dijk P; Sijens PE; Schmitz PI; Oudkerk M
Magn Reson Imaging; 1997; 15(5):535-41. PubMed ID: 9253997
[TBL] [Abstract][Full Text] [Related]
16. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
[TBL] [Abstract][Full Text] [Related]
17. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
[TBL] [Abstract][Full Text] [Related]
19. [Use of contrast agent in high-field MRI (3 T)].
Trattnig S; Ba-Ssalamah A; Nöbauer-Huhmann IM; Barth M; Pinker K; Mlynarik V
Radiologe; 2004 Jan; 44(1):56-64. PubMed ID: 14740095
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain.
Runge VM; Parker JR; Donovan M
Invest Radiol; 2002 May; 37(5):269-80. PubMed ID: 11979153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
